# ucb.com

> AI-optimized mirror of ucb.com containing 50 pages totalling 24,584 words of clean markdown content, structured data, and semantic HTML. Original source: https://ucb.com. Last updated: 2026-09-07T02:44:18.499Z.

Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG).

## Homepage

- [Inspired by Patients. Driven by Science.](/content/site-root.html): UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions (247 words)

## Articles & Blog Posts

- [Investors | UCB](/content/investors/index.html): Investors | UCB (2,304 words)
- [Innovation | UCB](/content/innovation/index.html): Innovation | UCB (510 words)
- [Share repurchase program | UCB](/content/investors/shareholders/share-repurchase-program/index.html): Share repurchase program | UCB (1,880 words)
- [UCB Worldwide | UCB](/content/worldwide/index.html): UCB Worldwide | UCB (1,501 words)
- [Shareholders meeting 2019 | UCB](/content/investors/shareholders/shareholders-meeting-2019/index.html): Shareholders meeting 2019 | UCB (177 words)
- [Digital Care Transformation | UCB](/content/solutions/digital-care-transformation/index.html): Digital Care Transformation | UCB (212 words)
- [Shareholders meeting 2021 | UCB](/content/investors/shareholders/shareholders-meeting-2021/index.html): Shareholders meeting 2021 | UCB (387 words)
- [Clinical Studies | UCB](/content/clinical-studies/overview/index.html): UCB researchers seek to understand, prevent and treat diseases. Clinical studies involving healthy volunteers and patients play a vital role in the development of new drugs. (967 words)
- [Immune to the impossible | UCB](/content/hcp/immune-to-the-impossible/index.html): Immune to the impossible | UCB (330 words)
- [Shareholders meeting 2024 | UCB](/content/investors/shareholders/shareholders-meeting-2024/index.html): Shareholders meeting 2024 | UCB (441 words)
- [Our positions | UCB](/content/about-ucb/our-positions/index.html): Our positions | UCB (759 words)
- [Download Center | UCB](/content/investors/download-center/index.html): Download Center | UCB (268 words)
- [Investigator-Initiated Studies | UCB](/content/innovation/funding/investigator-initiated-studies/index.html): Investigator-Initiated Studies | UCB (1,385 words)
- [Shareholders meeting 2017 | UCB](/content/investors/shareholders/shareholders-meeting-2017/index.html): Shareholders meeting 2017 | UCB (708 words)
- [Notification Art. 74 | UCB](/content/investors/shareholders/notification-art-74/index.html): Notification Art. 74 | UCB (161 words)
- [Eurobond 2015 - Disclaimer | UCB](/content/investors/download-center/eurobond-2015-disclaimer/index.html): Eurobond 2015 - Disclaimer | UCB (409 words)
- [Rheumacensus | UCB](/content/solutions/healthcare-professionals/rheumacensus/index.html): Rheumacensus | UCB (607 words)
- [Pipeline | UCB](/content/innovation/pipeline/index.html): Pipeline | UCB (528 words)
- [Shareholders meeting 2026 | UCB](/content/investors/ucb-shareholders/shareholders-meeting-2026/index.html): Shareholders meeting 2026 | UCB (324 words)
- [Peer-Reviewed Publications | UCB](/content/innovation/clinical-studies/data-transparency-policy/peer-reviewed-publications/index.html): Peer-Reviewed Publications | UCB (325 words)
- [Partnering | UCB](/content/about-ucb/collaborate-with-us/partnering/index.html): Partnering | UCB (618 words)
- [HCP policies | UCB](/content/hcp-policies/index.html): HCP policies | UCB (195 words)
- [Solutions | UCB](/content/solutions/index.html): Solutions | UCB (384 words)
- [Eurobond 2013 - Disclaimer | UCB](/content/investors/download-center/eurobond-2013-disclaimer/index.html): Eurobond 2013 - Disclaimer | UCB (326 words)
- [Publications | UCB](/content/innovation/publications/category-all/index.html): Publications | UCB (537 words)
- [Cimzia® - Axial spondyloarthritis | UCB](/content/solutions/products/cimzia-axial-spondyloarthritis-axspa/index.html): Cimzia® - Axial spondyloarthritis | UCB (270 words)
- [Reducing emissions | UCB](/content/about-ucb/sustainability/environmentals-sustainability/co2e/index.html): Reducing emissions | UCB (591 words)
- [About UCB | UCB](/content/about-ucb/index.html): About UCB | UCB (630 words)
- [Current studies | UCB](/content/innovation/clinical-studies/current-studies/index.html): Current studies | UCB (483 words)
- [Clinical guidelines | UCB](/content/hcp/women-of-childbearing-age/clinical-guidelines/index.html): Clinical guidelines | UCB (283 words)
- [Health of the Planet | UCB](/content/our-company/green-strategy/index.html): Health of the Planet | UCB (185 words)
- [Support of patient organisations in Europe | UCB](/content/support-of-patient-organisations-in-europe/index.html): Support of patient organisations in Europe | UCB (114 words)
- [Press releases | UCB](/content/newsroom/press-releases/index.html): Press releases | UCB (104 words)
- [Transparency notifications | UCB](/content/investors/shareholders/transparency-notifications/index.html): Transparency notifications | UCB (2,625 words)
- [Management | UCB](/content/about-ucb/management/index.html): Management | UCB (121 words)
- [Bimzelx® | UCB](/content/solutions/products/bimzelx/index.html): Bimzelx® | UCB (292 words)
- [Fintepla® | UCB](/content/our-products/fintepla/index.html): Fintepla® | UCB (131 words)
- [Patient Engagement | UCB](/content/about-ucb/sustainability/patient-engagement/index.html): Patient Engagement | UCB (316 words)
- [Materiality assessment exercise | UCB](/content/our-company/sustainability/ucb-materiality-update-results/index.html): Materiality assessment exercise | UCB (274 words)
- [2023 EMTN program | UCB](/content/investors/download-center/2023-emtn-program/index.html): 2023 EMTN program | UCB (49 words)
- [Cookie policy | UCB](/content/cookie-policy/index.html): Cookie policy | UCB (159 words)
- [EMTN 2022 program - disclaimer | UCB](/content/investors/download-center/emtn-2022-program-disclaimer/index.html): EMTN 2022 program - disclaimer | UCB (394 words)
- [Page Not Found | UCB](/content/node/41/index.html): Page Not Found | UCB (134 words)
- [UCB stories | UCB](/content/newsroom/ucb-stories/index.html): UCB stories | UCB (81 words)
- [Disclosure of payments | UCB](/content/disclosure-of-payments/index.html): Disclosure of payments | UCB (429 words)
- [2024 Eurobond documents | UCB](/content/investors/download-center/2024-eurobond-documents/index.html): 2024 Eurobond documents | UCB (48 words)
- [Newsroom | UCB](/content/stories-media/index.html): Newsroom | UCB (156 words)
- [Immunology | UCB](/content/solutions/digital-care-transformation/immunology/index.html): Immunology | UCB (175 words)
- [EMTN Notes documents | UCB](/content/investors/download-center/emtn-notes-documents/index.html): EMTN Notes documents | UCB (50 words)

## Resources

- [Full Page Index](/index.html): Browse all cached pages with rich metadata
- [About This Cache](/about.html): Methodology, technical details, and usage guidelines
- [XML Sitemap](/sitemap.xml): Machine-readable sitemap for crawler discovery
- [Robots.txt](/robots.txt): Crawler directives
- [AgentSite Network](https://agentsite.network/network.html): Public index of AgentSites and their machine-readable resources